Merck and Schering-Plough attempted to recreate information from a crucial meeting about a major study on Vytorin after a Congressional panel began an investigation, according to documents obtained by a Congressional subcommittee, the WSJ reports.
In a letter Friday, Rep. John Dingell (D-Mich.) and Rep. Bart Stupak (D-Mich.) asked why minutes of the companies’ ad [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment